Detalhe da pesquisa
1.
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).
Lancet
; 390(10103): 1654-1663, 2017 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28756902
2.
Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 145(1): 122-129, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28190649
3.
Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis.
Gynecol Oncol
; 143(2): 294-301, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27542967
4.
Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper.
Gynecol Oncol
; 132(1): 8-17, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24239753
5.
Cytokine use and survival in the first-line treatment of ovarian cancer: a Gynecologic Oncology Group Study.
Gynecol Oncol
; 127(3): 495-501, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23000389
6.
Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study.
Gynecol Oncol
; 125(1): 87-93, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22155678
7.
Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: a Gynecologic Oncology Group study.
Gynecol Oncol
; 121(2): 303-8, 2011 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21329967
8.
Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study.
Gynecol Oncol
; 116(1): 15-20, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19840887
9.
Clinical trial endpoints in ovarian cancer: report of an FDA/ASCO/AACR Public Workshop.
Gynecol Oncol
; 107(2): 173-6, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17950384
10.
Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study.
J Clin Oncol
; 22(19): 3902-8, 2004 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15459211
11.
Management of women who present with T4 breast cancer.
Am Surg
; 70(8): 662-6; discussion 666-7, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15328797
12.
Does the progression-free interval after primary chemotherapy predict survival after salvage chemotherapy in advanced and recurrent endometrial cancer?: a Gynecologic Oncology Group ancillary data analysis.
Cancer
; 116(23): 5407-14, 2010 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20737572
13.
Chemotherapy intensity and toxicity among black and white women with advanced and recurrent endometrial cancer: a Gynecologic Oncology Group Study.
Cancer
; 116(2): 355-61, 2010 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19924790
14.
American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants.
J Clin Oncol
; 27(1): 127-45, 2009 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19018081
15.
Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study.
Gynecol Oncol
; 105(1): 59-65, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17150247
16.
Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study.
J Clin Oncol
; 25(19): 2804-10, 2007 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17502627
17.
The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study.
Gynecol Oncol
; 106(1): 16-22, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17574073
18.
The role of maintenance therapy and novel taxanes in ovarian cancer.
Gynecol Oncol
; 102(2): 218-25, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16460787
19.
Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.
J Clin Oncol
; 24(1): 36-44, 2006 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16330675
20.
Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma: a Gynecologic Oncology Group study.
Cancer
; 107(9): 2197-205, 2006 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17001661